Atlas Trials

Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During EBUS-TBNA

Clinical trial NCT06033729 · COMPLETED

Trial details

NCT number
NCT06033729
Sponsor
Scarlata, Simone, M.D.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Lung CancerLung; NodeSedation ComplicationEndoscopy
Start date
2021-09-20
Primary completion
2022-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.